Suppr超能文献

秘鲁利马大都会地区女孩的父母对人乳头瘤病毒(HPV)疫苗接受度的相关因素。

Factors associated with parental acceptance of the HPV vaccine in girls from metropolitan Lima, Peru.

作者信息

Juárez-Leon Valeria, Calderón-Solano Delahnie, Poterico Julio A, Ybaseta-Medina Jorge, Azañedo Diego, Torres-Román J Smith

机构信息

Universidad Científica del Sur, Lima, Peru.

Universidad de Huánuco, Huánuco, Peru.

出版信息

BMC Public Health. 2025 Jul 3;25(1):2334. doi: 10.1186/s12889-025-23228-8.

Abstract

BACKGROUND

In 2022, cervical cancer was the second most common neoplasia among women in Peru, with 4809 cases and 2545 deaths reported. Infection with human papillomavirus (HPV) is a key factor in the development of this disease. Vaccination is the primary strategy for HPV prevention. Although HPV vaccination coverage has improved, evaluating acceptance profiles is crucial for effectively monitoring public immunization policies. We aimed to determine the associated factors with parental acceptance of the HPV vaccine in girls from Peru.

METHODS

An observational, analytical, and cross-sectional study was conducted with a sample of 204 parents of girls and adolescents aged 9 to 19 years in Metropolitan Lima. The dependent variable was acceptance of the HPV vaccine, while the independent variables included demographic data, level of knowledge about HPV, and socioeconomic and cultural factors.

RESULTS

A total of 204 parents participated in the study. Overall, 61.3% expressed willingness to vaccinate their daughters against HPV. Factors significantly associated with vaccine acceptance in the bivariate analysis included being a mother, being married, residing in the South-Central region, having a high monthly income, possessing private or public health insurance, and having a higher level of education. In both bivariate and multivariable analyses, having a daughter previously vaccinated against HPV was significantly associated with HPV vaccine acceptance, and remained the only independent predictor in the adjusted model (aPR = 1.25, 95% CI: 1.03–1.53,  = 0.023). Knowledge level about HPV was not significantly associated with vaccine acceptance in the adjusted model.

CONCLUSION

Prior experience with HPV vaccination was the strongest predictor of parental acceptance. Increasing awareness and addressing misconceptions through educational campaigns may enhance vaccine uptake.

摘要

背景

2022年,宫颈癌是秘鲁女性中第二常见的肿瘤,报告病例4809例,死亡2545例。人乳头瘤病毒(HPV)感染是该疾病发生的关键因素。接种疫苗是预防HPV的主要策略。尽管HPV疫苗接种覆盖率有所提高,但评估接受情况对于有效监测公共免疫政策至关重要。我们旨在确定秘鲁女孩父母接受HPV疫苗的相关因素。

方法

对利马大都会9至19岁女孩和青少年的204名父母进行了一项观察性、分析性横断面研究。因变量是对HPV疫苗的接受情况,自变量包括人口统计学数据、对HPV的了解程度以及社会经济和文化因素。

结果

共有204名父母参与了研究。总体而言,61.3%的父母表示愿意为女儿接种HPV疫苗。在双变量分析中,与疫苗接受情况显著相关的因素包括母亲身份、已婚、居住在中南部地区、月收入高、拥有私人或公共医疗保险以及教育程度较高。在双变量和多变量分析中,女儿之前接种过HPV疫苗与HPV疫苗接受情况显著相关,并且在调整模型中仍然是唯一的独立预测因素(调整后风险比=1.25,95%置信区间:1.03-1.53,P=0.023)。在调整模型中,对HPV的了解程度与疫苗接受情况没有显著关联。

结论

HPV疫苗接种的既往经历是父母接受程度的最强预测因素。通过开展教育活动提高认识并消除误解可能会提高疫苗接种率。

相似文献

1
Factors associated with parental acceptance of the HPV vaccine in girls from metropolitan Lima, Peru.
BMC Public Health. 2025 Jul 3;25(1):2334. doi: 10.1186/s12889-025-23228-8.
2
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3.
3
Human papillomavirus vaccine uptake and its determinants among women in Africa: an umbrella review.
Front Public Health. 2025 Jun 5;13:1537250. doi: 10.3389/fpubh.2025.1537250. eCollection 2025.
4
Promoting HPV vaccination among adolescent girls in low-resource areas of China: A multi-centered qualitative study.
Hum Vaccin Immunother. 2025 Dec;21(1):2521940. doi: 10.1080/21645515.2025.2521940. Epub 2025 Jun 26.
5
Knowledge of human papillomavirus and the human papillomavirus vaccine in European adolescents: a systematic review.
Sex Transm Infect. 2016 Sep;92(6):474-9. doi: 10.1136/sextrans-2015-052341. Epub 2016 Jan 20.
6
Intent to Receive Human Papillomavirus Vaccination among School-going Pre-teens and Adolescent Girls.
Int J MCH AIDS. 2025 May 31;14:e012. doi: 10.25259/IJMA_33_2025. eCollection 2025.
7
Factors affecting caregivers' HPV vaccination decisions for adolescent girls: A secondary analysis of a Chinese RCT.
PLoS One. 2025 Jun 17;20(6):e0324260. doi: 10.1371/journal.pone.0324260. eCollection 2025.
8
Two-dose schedules for human papillomavirus vaccine: Systematic review and meta-analysis.
Vaccine. 2017 May 19;35(22):2892-2901. doi: 10.1016/j.vaccine.2017.03.096. Epub 2017 Apr 25.

本文引用的文献

1
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
4
[Factors associated with the acceptability of the human papillomavirus vaccine, Huanuco, Peru].
Rev Chilena Infectol. 2020 Dec;37(6):694-700. doi: 10.4067/S0716-10182020000600694.
5
Barriers to and Facilitators of Human Papillomavirus Vaccination Among People Aged 9 to 26 Years: A Systematic Review.
Sex Transm Dis. 2021 Dec 1;48(12):e255-e262. doi: 10.1097/OLQ.0000000000001407.
6
Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation.
Front Public Health. 2021 Jan 20;8:552028. doi: 10.3389/fpubh.2020.552028. eCollection 2020.
7
Cervical cancer mortality in Peru: regional trend analysis from 2008-2017.
BMC Public Health. 2021 Jan 26;21(1):219. doi: 10.1186/s12889-021-10274-1.
8
HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019.
Prev Med. 2021 Mar;144:106399. doi: 10.1016/j.ypmed.2020.106399. Epub 2020 Dec 31.
9
Biological and clinical aspects of HPV-related cancers.
Cancer Biol Med. 2020 Nov 15;17(4):864-878. doi: 10.20892/j.issn.2095-3941.2020.0370. Epub 2020 Dec 15.
10
Barriers to vaccination in Latin America: A systematic literature review.
Vaccine. 2020 Jan 16;38(3):470-481. doi: 10.1016/j.vaccine.2019.10.088. Epub 2019 Nov 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验